Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
McGill University
$120,000.00
Investigating the impact of inulin on the gut microbiome to potentiate cancer immunotherapy
EF 2025-26
Résumé
Cancer is the leading cause of death in Canada, despite recent Nobel prize-winning discoveries in immunotherapy. This treatment strategy improves the treatment of multiple forms of cancer by strengthening the patient's immune system against the disease. Although immunotherapy has become the first therapy option for many patients, with remarkable outcome, around 40% of patients do not respond well to the therapy. We and others have shown that the type of bacteria residing in the patient gut, called the gut microbiota, is a key determining factor in how a patient will respond to immunotherapy. We believe that by changing the gut microbiota, we can improve response to immunotherapy. A diet rich in fibre has been associated with a positive response to cancer immunotherapy. In particular, the dietary fibre inulin has been shown to promote the growth of bacteria associated with positive immunotherapy outcome in mice with cancer.
The specific objective of the present proposal is to use dietary fibres, including inulin, to change the gut microbiota and maximize the chances that a patient responds to immunotherapy. To achieve this, we will identify gut bacteria that mediate the beneficial effect of inulin. Overall, the present project will advance microbiota-focused approaches in cancer immunotherapy and will pioneer a more accessible way to improve therapy outcomes through the application of dietary fibre.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
560249
Name
Prattico Catherine V
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Investigating the impact of inulin on the gut microbiome to potentiate cancer immunotherapy
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Bacterial Metabolism; Cancer; Dietary Fibre; Fluorescence-Activated Cell Sorting; Gut Microbiome; Immunotherapy; Inulin; Metatranscriptomics; Prebiotic; Short Chain Fatty Acids
Abstract
Cancer is the leading cause of death in Canada, despite recent Nobel prize-winning discoveries in immunotherapy. This treatment strategy improves the treatment of multiple forms of cancer by strengthening the patient's immune system against the disease. Although immunotherapy has become the first therapy option for many patients, with remarkable outcome, around 40% of patients do not respond well to the therapy. We and others have shown that the type of bacteria residing in the patient gut, called the gut microbiota, is a key determining factor in how a patient will respond to immunotherapy. We believe that by changing the gut microbiota, we can improve response to immunotherapy. A diet rich in fibre has been associated with a positive response to cancer immunotherapy. In particular, the dietary fibre inulin has been shown to promote the growth of bacteria associated with positive immunotherapy outcome in mice with cancer.
The specific objective of the present proposal is to use dietary fibres, including inulin, to change the gut microbiota and maximize the chances that a patient responds to immunotherapy. To achieve this, we will identify gut bacteria that mediate the beneficial effect of inulin. Overall, the present project will advance microbiota-focused approaches in cancer immunotherapy and will pioneer a more accessible way to improve therapy outcomes through the application of dietary fibre.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Prattico, Catherine V
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~